Thrombotic dysfibrinogenemia. Fibrinogen "Caracas V" relation between very tight fibrin network and defective clot degradability.
Fibrinogen Caracas V is a thrombotic dysfibrinogenemia with an Aalpha 532 Ser-->Cys mutation characterized by a tight fibrin network formed of thin fibers responsible for a less porous clot than a normal one. In the present work, fibrinogen Caracas V is further characterized in order to understand the relationship between the structural defect and thrombophilia. This thrombotic disorder has been attributed to a tight fibrin network responsible for a decreased permeation of flow through the clot, leading to defective thrombus lysis due to a diminished availability of fibrinolytic enzymes to the inner fibrin surface. Correction of clot structure anomaly, by addition of dextran 40 to fibrinogen before clotting, induces an improvement in fibrin degradation that was attributed to an increase in porosity. The pulmonary embolism observed in this family has been related to an hyper rigidity of the clot, an anomaly that is also corrected by dextran. Furthermore, this abnormal fibrinogen binds more albumin than does normal fibrinogen, a phenomenon attributed to the mutation of serine in Aalpha-532 by cysteine. Therefore, this fibrinogen shows a striking similarity to the fibrinogen Dusart, allowing us to confirm that the alphaC-terminal part of fibrinogen plays an important role in fibrin structure, and to conclude that the anomaly of fibrin network observed in fibrinogen Caracas V is responsible for a deficient thrombus lysis.
Marchi
R
R
Laboratorio de Fisiopatología, Instituto Venezolano de Investigaciones Científicas, IVIC, Caracas, Venezuela.
Mirshahi
S S
SS
Soria
C
C
Mirshahi
M
M
Zohar
M
M
Collet
J P
JP
de Bosch
N B
NB
Arocha-Piñango
C L
CL
Soria
J
J
D000418:Albumins / Q000378:metabolism; D019943:Amino Acid Substitution; D001777:Blood Coagulation / Q000187:drug effects / Q000235:genetics; D020147:Coagulation Protein Disorders / Q000097:blood / Q000235:genetics / Q000503:physiopathology*; D003911:Dextrans / Q000494:pharmacology; D005337:Fibrin / Q000235:genetics / Q000378:metabolism / Q000648:ultrastructure; D015241:Fibrinogens, Abnormal / Q000235:genetics / Q000378:metabolism*; D005342:Fibrinolysis / Q000187:drug effects / Q000235:genetics; D006801:Humans; D018613:Microscopy, Confocal; D009154:Mutation; D019851:Thrombophilia / Q000097:blood / Q000235:genetics
D000418:Albumins; D003911:Dextrans; D015241:Fibrinogens, Abnormal; D005337:Fibrin